All News

Although the adverse effects of the lockdown were inevitable for cardiology patients, increased technology services may offer an opportunity for expanded patient access.

In the medieval period, what was believed to be the only cure for scofula, a form of tuberculosis?

Top news of the week from Pharmacy Times®.

Many clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.

With election season intensifying, 35% of voters said drug pricing is among the most important issues influencing their vote in November.

Although researchers are testing modifications of a drug used to cure a fatal coronavirus found in cats, it shows enough action against SARS-CoV-2 to proceed to clinical trials.

Despite contrary studies, new evidence indicates premenopausal women fair better after a heart attack than men.

According to the study authors, with a higher antigen valency, antibodies have more sites to latch onto; however, including a higher antigen valency in a vaccine does not mean it will work better.

The patients were identified for testing through contact tracing or by developing symptoms, with 22% never developing symptoms, 20% initially asymptomatic but developing symptoms later, and 58% being symptomatic at their initial test.

Study suggests up to 75% of online pharmacies are illegitimate and pose serious health concerns.

Although 68% of adults say they get a flu vaccine at least some years, poll results found that younger adults and Black Americans are significantly less likely.

Despite an ongoing long-term debate, no link was found between cancer and the use of ACE inhibitors, beta blockers, and other common antihypertensive drugs.

In a Pharmacy Times' webcast on immunization practices during the pandemic, thought leaders discussed considerations and best practices regarding the administration of vaccinations.

The study evaluated whether conditions such as depression in adolescence are associated with a higher risk of cardiovascular disease in adulthood.

In a viewpoint article published in JAMA, researchers proposed reforms that could improve the authorization and approval process during public health crises to increase the public’s trust in the agency.

Azacitidine showed an overall survival benefit among patients with acute myeloid leukemia compared with a placebo.

The development of the COVID-19 vaccine AZD1222 has expanded into a phase 3 trial that is enrolling 30,000 adults aged 18 years or older to assess its safety, efficacy, and immunogenicity.

Oral chemotherapy may be an important option for patients during the COVID-19 pandemic, as it would allow them to receive treatment at home.

An analysis of phase 3 study data found that 99% of patients who received inclisiran showed a significant placebo-adjusted reduction in low-density lipoprotein cholesterol (LDL-C).

From navigating online classes to adjusting to either cancelled or switched experiential learning rotations, the pandemic has changed the lives of pharmacy students worldwide.

Athletes and endurance athletes are at an increased risk of atrial fibrillation.

Contrary to previous studies, the rate of cognitive impairment has increased over the past 20 years.

A recent survey showed that 86% of community pharmacists plan to offer the COVID-19 vaccines once they become available, whereas another 12% responded that they want more information to determine their decision.

A study linked cognitive impariment to worse prognoses in a larger group of heart failure patients.

Women who typically have a better prognosis in the primary breast cancer setting experienced worse survival after a second primary breast cancer.

Evolocumab in combination with statins and other lipid-lowering therapies was found to significantly reduce low-density lipoprotein cholesterol in pediatric patients with heterozygous familial hypercholesterolemia.

Despite improvements in the understanding and treatment of chemotherapy-induced nausea and vomiting (CINV), nausea and emesis continue to be a distressing adverse event for patients.

The effect of bacteria in the intestines on myelin and the brain may worsen the symptoms of multiple sclerosis.